bit.bio

$75M raised across 2 rounds tracked here. Latest: Series D, $25M on 22 October 2026.

Latest round Series DCountry United KingdomSector Other

Rounds 2

bit.bio raised $25 million in Series D funding.

Amount: $25M
Stage: Series D
Announced: 22 October 2026
Investors: M&G Investments, Dr Jonathan Milner
Use of funds: Expand its range of human cell models and make them available to more pharmaceutical, biotechnology and research organisations.
Checked: Amount and date checked against the press source
Source: bit.bio Raises $25M in Series D Funding - FinSMEs FinSMEs

Series C funds product development, global expansion, manufacturing capacity and AI dataset generation.

Amount: $50M
Stage: Series C
Announced: 9 January 2026
Lead: M&G Investments
Use of funds: Series C funds product development, global expansion, manufacturing capacity and AI dataset generation.
Checked: Announced by the company
Sources: bit.bio Raises $50 Million Series C Led by M G To Scale Human Cell Programming Platform mandg.com
bit.bio Raises $50 Million Series C Led by M G To Scale Human Cell Programming Platform pulse2.com

Builds human cell models for drug discovery, disease research, functional genomics and toxicology.

How much has bit.bio raised?

bit.bio has raised $75M across 2 rounds tracked by FundraiseBase. The latest is Series D of $25M, announced on 22 October 2026.

Who invested in bit.bio?

M&G Investments led. Investors include M&G Investments and Dr Jonathan Milner.